Takeda Pharmaceutical to Acquire Paradigm Therapeutics Limited OSAKA, Japan & CAMBRIDGE, England -- Takeda Pharmaceutical Company Limited ("Takeda") today announced that Takeda and Paradigm ...
An innovative liquid crystal technology that offers the promise of new drugs which may more effectively manage cancer and other diseases has been developed. The most recent research involving Liquid ...
It’s a fairly common occurrence for ASX-listed companies to start slowing down their operations as the holiday season draws near – but not so for Paradigm Pharmaceuticals (ASX:PAR), which only just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results